Skip to main content
. 2023 Jul 5;15(7):e41413. doi: 10.7759/cureus.41413

Table 1. Blood, urine, and cerebrospinal fluid test results.

MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; WBC = white blood cell; AST = aspartate transaminase; ALT = alanine transaminase; TSH = thyroid-stimulating hormone; ACTH = adrenocorticotropic hormone; LH = luteinizing hormone; FSH = follicle-stimulating hormone; GH = growth hormone; IGF-1 = insulin-like growth factor 1; CK = creatine kinase; anti-MOG = anti-myelin oligodendrocyte glycoprotein; NMO = neuromyelitis optica; AQP4 = aquaporin‐4

Investigations Values
Complete blood count
Hemoglobin 11.3 g/dL
MCV 60.7 fL
MCH 19.9 pg
WBC 15.15 × 103/µL
Biochemistry
Osmolality 283 mOsmol/kg (normal: 275–295)
Glucose 79 mg/dL
Sodium 128 mmol/L (normal: 136–145)
Total Bilirubin 0.22 mg/dL
AST 44 U/L
ALT 29 U/L
Endocrinology
TSH 3.75 mIU/L (normal: 0.7–5.9)
T4 17.5 pmol/L (normal: 12.3–22.8)
Prolactin 178.4 ng/mL (normal: 4.8–23.3)
ACTH 74 pg/mL (normal: 7.2–63.3)
Cortisol AM 11.5 µg/dL (normal: 3.7–9.4)
LH <0.1 mIU/mL
FSH 0.3 mIU/mL (normal: 0.2–11.1)
GH 1.88 ng/mL (normal: 0–10)
IGF-1 67 ng/mL (normal: 34.2–155)
Specific blood tests
CK 67 U/L (normal: 0–149)
Alpha-fetoprotein 2.2 ng/mL (normal: 0–8.3)
Neuron-specific enolase 16.3 ng/mL (normal: 0–12.5)
Paraneoplastic autoantibodies Negative
Anti-neuronal nuclear antibody (I, II, III) Negative
Anti-glial nuclear antibody (I) Negative
Purkinje cell cytoplasmic antibody (I, II, III) Negative
Normetanephrine 65.3 pg/mL
Metanephrines 46.5 pg/mL (normal: 0–88.0)
Urine investigations
Osmolality 260 mOsmol/kg (normal: 50–1400)
Specific gravity <1.005
Sodium 26 mmol/L
VMA/Creatinine 5.7 mg/g creat (normal: 0–11)
HVA/Creatinine 14 mg/g creat (normal: 0–22)
Cerebrospinal fluid investigations
Glucose 59 mg/dL
Protein 16 mg/dL
WBC 4
Neutrophils 0%
Lymphocytes 100%
Viral panel Negative
Culture Negative
Lactate 1.9 mmol/L (normal: 1.1–2.8)
Oligoclonal bands Positive for oligoclonal bands
Anti-MOG antibodies Negative
NMO/AQP4 IgG Negative